Registrieren

Registierung erfolgt in Kürze...
Fleebs-Logo
Details werden geladen...

NetraMark Provides Second Quarter Update and Highlights Continued Commercial, Scientific, Regulatory and Capital Markets Momentum | The Manila Times

TORONTO, May 14, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the 'Company” or 'NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered precision analytics in the pharmaceutical industry, today provided a business update highlighting key accomplishments during its second fiscal quarter ended March 31, 2026, as well as subsequent developments.

Ähnliche Seiten

https://www.manilatimes.net/2026/05/16/tmt-newswire/globenewswire/eaglenxt-provides-shareholder-update-as-second-quarter-momentum-builds-across-defense-and-commercial-markets/2345303

EagleNXT Provides Shareholder Update as Second Quarter Momentum Builds Across Defense and Commercial Markets | The Manila Times

https://www.manilatimes.net/2026/05/16/tmt-newswire/globenewswire/eaglenxt-provides-shareholder-update-as-second-quarter-momentum-builds-across-defense-and-commercial-markets/2345303
https://www.manilatimes.net/2026/05/15/tmt-newswire/globenewswire/indaptus-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update/2344835

Indaptus Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update | The Manila Times

https://www.manilatimes.net/2026/05/15/tmt-newswire/globenewswire/indaptus-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update/2344835
https://www.manilatimes.net/2026/05/16/tmt-newswire/globenewswire/plus-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-update-on-reyobiq-clinical-program-and-cnside-commercial-rollout/2345286

Plus Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update on REYOBIQ™ Clinical Program and CNSide® Commercial Rollout | The Manila Times

https://www.manilatimes.net/2026/05/16/tmt-newswire/globenewswire/plus-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-update-on-reyobiq-clinical-program-and-cnside-commercial-rollout/2345286
https://www.manilatimes.net/2026/05/15/tmt-newswire/globenewswire/dare-bioscience-reports-first-quarter-2026-financial-results-and-provides-business-update/2344377

Daré Bioscience Reports First Quarter 2026 Financial Results and Provides Business Update | The Manila Times

https://www.manilatimes.net/2026/05/15/tmt-newswire/globenewswire/dare-bioscience-reports-first-quarter-2026-financial-results-and-provides-business-update/2344377
https://www.manilatimes.net/2026/05/08/tmt-newswire/globenewswire/tvardi-therapeutics-announces-first-quarter-2026-results-and-provides-business-update/2339409

Tvardi Therapeutics Announces First Quarter 2026 Results and Provides Business Update | The Manila Times

https://www.manilatimes.net/2026/05/08/tmt-newswire/globenewswire/tvardi-therapeutics-announces-first-quarter-2026-results-and-provides-business-update/2339409
https://www.manilatimes.net/2026/05/15/tmt-newswire/globenewswire/airjoule-technologies-announces-first-quarter-2026-results-and-provides-business-update/2344384

AirJoule Technologies Announces First Quarter 2026 Results and Provides Business Update | The Manila Times

https://www.manilatimes.net/2026/05/15/tmt-newswire/globenewswire/airjoule-technologies-announces-first-quarter-2026-results-and-provides-business-update/2344384